Abstract:Opioid use disorder (OUD) continuously poses major public health challenges and social implications worldwide with dramatic rise of opioid dependence leading to potential abuse. Despite that a few pharmacological agents have been approved for OUD treatment, the efficacy of said agents for OUD requires further improvement in order to provide safer and more effective pharmacological and psychosocial treatments. Proteins including mu, delta, kappa, nociceptin, and zeta opioid receptors are the direct targets of opioids and play critical roles in therapeutic treatments. The protein-protein interaction (PPI) networks of the these receptors increase the complexity in the drug development process for an effective opioid addiction treatment. The report below presents a PPI-network informed machine-learning study of OUD. We have examined more than 500 proteins in the five opioid receptor networks and subsequently collected 74 inhibitor datasets. Machine learning models were constructed by pairing gradient boosting decision tree (GBDT) algorithm with two advanced natural language processing (NLP)-based autoencoder and Transformer fingerprints for molecules. With these models, we systematically carried out evaluations of screening and repurposing potential of more than 120,000 drug candidates for four opioid receptors. In addition, absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties were also considered in the screening of potential drug candidates. Our machine-learning tools determined a few inhibitor compounds with desired potency and ADMET properties for nociceptin opioid receptors. Our approach offers a valuable and promising tool for the pharmacological development of OUD treatments.

Machine Learning Harnesses Molecular Dynamics to Discover New $μ$ Opioid Chemotypes

Machine Learned Classification of Ligand Intrinsic Activities at Human μ-Opioid Receptor

Machine Learned Classification of Ligand Intrinsic Activities at Human mu-Opioid Receptor

Binding Pathway of Opiates to $μ$ Opioid Receptors Revealed by Unsupervised Machine Learning

Structural Basis for Bifunctional Peptide Recognition at Human Δ-Opioid Receptor

Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.

Machine-learning Repurposing of DrugBank Compounds for Opioid Use Disorder

Structure–Kinetics Relationships of Opioids from Metadynamics and Machine Learning Analysis

Molecular Modeling on Kappa Opioid Receptor and Its Interaction with Nonpeptide Kappa Opioid Agonists

Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks

Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning Intelligence

Multiobjective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex

Computational Insights into the Molecular Mechanisms of Differentiated Allosteric Modulation at the Mu Opioid Receptor by Structurally Similar Bitopic Modulators

Modern Semiempirical Electronic Structure Methods and Machine Learning Potentials for Drug Discovery: Conformers, Tautomers, and Protonation States

Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method

Understanding and predicting ligand efficacy in the mu-opioid receptor through quantitative dynamical analysis of complex structures

Multi-objective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex

Machine learning-aided generative molecular design

Determination of structural factors affecting binding to mu, kappa and delta opioid receptors

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers.